Operating Segments

6 Months Ended

Jun. 30, 2021

Operating Segments

Operating Segments

Note 10. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended
	June 30,
	2021		2020
Revenues
Public Health Solutions	$	214,824	$	468,009
Specialized BioTherapeutics		—		37,279
Total	$	214,824	$	505,288
Loss from Operations
Public Health Solutions	$	(231,954)	$	(50,737)
Specialized BioTherapeutics		(1,720,566)		(1,808,652)
Corporate		(1,057,125)		(954,483)
Total	$	(3,009,645)	$	(2,813,872)
Amortization and Depreciation Expense
Public Health Solutions	$	311	$	7,318
Specialized BioTherapeutics		1,862		3,167
Corporate		6,667		7,317
Total	$	8,840	$	17,802
Other Income, Net
Specialized BioTherapeutics	$	41,001		35,091
Corporate		206,834		2,018
Total	$	247,835	$	37,109
Share-Based Compensation
Public Health Solutions	$	7,189	$	8,377
Specialized BioTherapeutics		28,731		18,962
Corporate		44,701		53,664
Total	$	80,621	$	81,003

	Six Months Ended
	June 30,
	2021		2020
Revenues
Public Health Solutions	$	362,417	$	1,376,818
Specialized BioTherapeutics		—		53,024
Total	$	362,417	$	1,429,842
Loss from Operations
Public Health Solutions	$	(362,735)	$	(209,239)
Specialized BioTherapeutics		(2,832,974)		(9,166,503)
Corporate		(2,047,543)		(1,911,919)
Total	$	(5,243,252)	$	(11,287,661)
Amortization and Depreciation Expense
Public Health Solutions	$	627	$	14,621
Specialized BioTherapeutics		3,761		6,237
Corporate		13,351		14,590
Total	$	17,739	$	35,448
Other Income/(Loss), Net
Specialized BioTherapeutics	$	125,635	$	68,706
Corporate		(6,671)		23,965
Total	$	118,964	$	92,671
Share-Based Compensation
Public Health Solutions	$	13,484	$	17,842
Specialized BioTherapeutics		58,310		44,251
Corporate		103,632		82,601
Total	$	175,426	$	144,694

	As of		As of
	June 30,		December 31,
	2021		2020
Identifiable Assets
Public Health Solutions	$	123,427	$	176,447
Specialized BioTherapeutics		34,272		147,784
Corporate		29,452,590		19,567,004
Total	$	29,610,289	$	19,891,235